Citation: M. Michael et Jr. Zalcberg, Chemotherapy for advanced colorectal cancer - It can improve quality of care and offer modest increases in survival, BR MED J, 321(7260), 2000, pp. 521-522
Citation: M. Michael et Jr. Zalcberg, The optimal 5-fluorouracil regimen for the adjuvant therapy of colon cancer: Where to from here?, ANN ONCOL, 11(8), 2000, pp. 915-918
Authors:
Parisot, JP
Leeding, KS
Hu, XF
DeLuise, M
Zalcberg, JR
Bach, LA
Citation: Jp. Parisot et al., Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line, BREAST CANC, 55(3), 1999, pp. 231-242
Authors:
de Silva, MG
Kantharidis, P
Scherer, SW
Rayeroux, K
Campbell, L
Tsui, LC
Zalcberg, JR
Citation: Mg. De Silva et al., Physical mapping of a tandem duplication on the long arm of chromosome 7 associated with a multidrug resistant phenotype, CANC GENET, 110(1), 1999, pp. 28-33
Authors:
Le Chevalier, T
Berille, J
Zalcberg, JR
Millward, MJ
Monnier, A
Douillard, JY
McKeage, MJ
James, R
Soulas, F
Loret, C
Bougon, N
Bizzari, JP
Citation: T. Le Chevalier et al., Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer, SEMIN ONCOL, 26(3), 1999, pp. 13-18
Authors:
Parisot, JP
Hu, XF
DeLuise, M
Zalcberg, JR
Citation: Jp. Parisot et al., Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line, BR J CANC, 79(5-6), 1999, pp. 693-700
Authors:
Hu, XF
Slater, A
Kantharidis, P
Rischin, D
Juneja, S
Rossi, R
Lee, G
Parkin, JD
Zalcberg, JR
Citation: Xf. Hu et al., Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia, BLOOD, 93(12), 1999, pp. 4086-4095